Background Coronary sinus reducer (CSR) implantation is the only guideline-recommended percutaneous treatment for patients ...
CAR T-cell therapy successfully cleared anti-HLA antibodies to enable kidney transplantation in three highly sensitized ...
With refractory orebodies becoming central to future gold supply, processing solutions with Glencore Tech's Albion Process are moving into focus.
ORR and 70% CRc in venetoclax-naïve and 48% ORR and 24% CRc in venetoclax-experienced patients at the recommended 600 mg once ...
In the darkness, the stage seems completely empty. Then, an explosion of sparkles makes you think you’re seeing the stars of ...
Shares of ADC Therapeutics SA (NYSE:ADCT) were trading at $1.54, down 49%, or $1.54, after the firm disclosed top-line data from the phase III Lotis-5 confirmatory trial testing Zynlonta ...
Pooled analysis of 24 adults and children with KMT2Ar, NPM1m, or NUP98r acute leukemia who resumed revumenib post-transplant shows favorable ...
A blood test following CAR T-cell therapy for relapsed/refractory mantle cell lymphoma (MCL) appears to do a better job than PET-CT scans at predicting which patients have poor prognoses, a small, ...
A recent study published in the Indian Journal of Otolaryngology and Head & Neck Surgery March 2024 demonstrates that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results